Journal profile · ENDOCRINOLOGY & METABOLISM
Endocrinology Diabetes & Metabolism
ISSN 2398-9238 · John Wiley & Sons
Endocrinology Diabetes & Metabolism: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.4 (journal website); fully open access; APC about USD 3,440; median 98 days to acceptance (97 articles, last 24 months); acceptance rate 35% (journal website); 132 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Endocrinology Diabetes & Metabolism is published by John Wiley & Sons and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Diabetes Treatment and Management, Diabetes Management and Research and Diabetes, Cardiovascular Risks, and Lipoproteins, together about 35.2% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Endocrinology, Diabetes & Metabolism is a peer-reviewed, open access, interdisciplinary journal dedicated to publishing research across diabetes and the continuum of metabolic disease. The journal considers articles and reviews which focus on the clinical and scientific aspects of endocrinology, the clinical application of molecular endocrinology, diabetes care and clinical management. It also welcomes work on new or existing diabetes therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. "Metabolism" may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and papers addressing drug safety and tolerability are also welcomed. Please note we do not consider epidemiology papers. At Endocrinology, Diabetes & Metabolism, we aim to be a truly global forum for research, and we think that the best research should be published and made widely accessible as quickly as possible. We advocate the principles of sound science publishing. We only accept papers where the conclusions are substantiated by the data presented, while deemphasizing the importance of novelty. If the science is reliable and sound, we will publish. Endocrinology, Diabetes & Metabolism publishes original papers submitted directly to the journal and those referred from a select group of prestigious journals published by Wiley In order for research to advance, negative results, which often make a valuable contribution to the field, should be published. However, articles containing negative or null results are frequently not considered for publication or rejected by journals. We welcome papers of this kind, where appropriate and valid power calculations are included that give confidence that a negative result can be relied upon. Endocrinology, Diabetes & Metabolism is a Wiley Open Access journal, one of a series of peer reviewed titles publishing quality research with speed and efficiency. For further information visit the Wiley Open Access website. Keywords Clinical endocrinology, clinical medicine, endocrine disease, endocrine tumors, endocrine tumors, endocrinology, clinical endocrinology, genetic, genetics, hormones, hormone therapy, oncology, pediatrics, pediatrics, thyroid, adrenal, pituitary, parathyroid, testis, ovary, estrogen, testosterone, corticosteroids, gro
From the journal's Aims & Scope
Research area (LetPub): ENDOCRINOLOGY & METABOLISM
Editor-in-chief Marcus HompeschPublisher website
Editorial board by country: 2 in mainland China (about 10%); most named United States 7, United Kingdom 6, Mainland China 2, India 2, Japan 1 (21 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes Treatment and ManagementMedicine13.3%
- Diabetes Management and ResearchMedicine11.6%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine10.4%
- Diabetes and associated disordersBiochemistry, Genetics and Molecular Biology6.6%
- Pancreatic function and diabetesMedicine5.3%
- Hyperglycemia and glycemic control in critically ill and hospitalized patientsMedicine5%
- Diabetes Management and EducationMedicine4.3%
- Liver Disease Diagnosis and TreatmentMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPMCEmbasePublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.4Publisher website ·
- Impact factor (publisher) 2025
- 3.4Publisher website ·
- CiteScore 2026-06
- 5.1LetPub ·
- CiteScore (publisher)
- 5.1Publisher website ·
- CiteScore (publisher) 2025
- 5.1Publisher website ·
- SJR 2026-06
- 0.99LetPub ·
- SNIP 2026-06
- 1.06LetPub ·
- h-index
- 39OpenAlex ·
- i10-index
- 240OpenAlex ·
- 2-year mean citedness
- 2.78OpenAlex ·
- Self-citation rate
- 2.9%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 117LetPub ·
- Articles per year (publisher) 2025
- 119Publisher website ·
- Downloads per year (publisher) 2025
- 299,665Publisher website ·
Articles by year OpenAlex count · 920 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 187 | 187 | 84 |
| 2025 | 132 | 132 | 561 |
| 2024 | 76 | 76 | 454 |
| 2023 | 76 | 76 | 734 |
| 2022 | 79 | 79 | 946 |
| 2021 | 104 | 104 | 1,440 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
98 daysMedian, submission to acceptance · P25–P75 57 days – 145 days
- Acceptance to online
- median 22 days (97 articles)
- Submission to online
- median 126 days
- Sample
- 97 articles with submission and acceptance dates (325 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Acceptance rate (publisher)
- 35%Publisher website ·
- Acceptance rate (publisher) 2025
- 35%Publisher website ·
- Submission to first decision
- 20 daysPublisher website ·
- Submission to first decision 2025
- 20 daysPublisher website ·
- Submission to acceptance 2025
- 90 daysPublisher website ·
- Acceptance to publication 2025
- 21 daysPublisher website ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,440 / GBP 2,190 / EUR 3,130 | Yes | CC BY | |
| OpenAlex | USD 3,280 / EUR 2,490 / GBP 2,190 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Reference style
- Author–date
- First submission
- Free format: the journal's layout is not required
- Not considered
- epidemiology papers
Policy excerpts from the journal's websitePublication ethics, Peer review
- Publication ethics 5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Editorial Review and AcceptanceEndocrinology, Diabetes & Metabolism accepts papers that are relevant to our readership and reflect valid science i.e. conclusions drawn need to be substantiated by the data, but novelty, insight and impact are not paramount. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editors-in-Chief determine…
Source ↗Publisher website ·- Peer review Peer Review
Endocrinology, Diabetes & Metabolism maintains the highest standards of peer review while increasing the efficiency of the process. All research articles published in the journal undergo full peer review, and we pursue editorial approaches that may help us avoid bias. We do our utmost to judge research objectively on its own merits and to avoid favoring research, for example, from particular insti…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- John Wiley & Sons
- ISSN
- 2398-9238
- Latest issue on the website
- Volume 9, Issue 5 (September 2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Endocrinology Diabetes & Metabolism
What CAS zone is Endocrinology Diabetes & Metabolism in?
In the 2025 upgraded edition of the CAS Journal Ranking, Endocrinology Diabetes & Metabolism is in Zone 4 of Medicine, and in Zone 4 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Endocrinology Diabetes & Metabolism?
The journal's website gives an impact factor of 3.4 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 5.1, h-index 39.
How long does peer review take at Endocrinology Diabetes & Metabolism?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 98 days (interquartile range 57–145 days); the journal's website gives an acceptance rate of 35% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Endocrinology Diabetes & Metabolism?
According to the journal's author guidelines: Reference style: Author–date; First submission: Free format: the journal's layout is not required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Endocrinology Diabetes & Metabolism based?
Of the 21 board members whose country the journal's board page names, 2 (about 10%) are in mainland China; the countries named most often are United States (7), United Kingdom (6) and Mainland China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Endocrinology Diabetes & Metabolism?
According to LetPub and DOAJ records, Endocrinology Diabetes & Metabolism is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science, MEDLINE, PMC and Embase; that list has not been checked against each database.
Is Endocrinology Diabetes & Metabolism open access, and what is the APC?
Endocrinology Diabetes & Metabolism is a fully open-access journal. APC about USD 3,440.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .